Question? Call us
212-363-7500Choose your preferred way to stay informed of new case launches and settlement deadlines
On July 10, 2024, the Centers for Medicare and Medicaid Services ("CMS") issued proposed payment rates for hospital outpatient and Ambulatory Surgical Center ("ASC") services. That same day, Piper Sandler released a note stating that under the proposed CMS rules, reimbursement for CVRx's Barostim heart failure device has been reduced by 38.1% for ASC services and by 32.9% for Hospital Outpatient Department services. Following this news, CVRx's stock price dropped over 38% the same day.
In order to be eligible to join the CVRX class action lawsuit, you must have incurred a loss on shares of CVRx, Inc. purchased during the class period listed above.
TOP